Paul Little

Operating Partner

Operating Partner at Lundbeckfonden BioCapital.

Paul Little joined the early stage biotech investment unit Lundbeckfonden Emerge in 2016 as an associate. Paul’s focus is on scientific evaluation and commercial assessment of early investment opportunities. He is CEO of Vesper Biotechnology and Board Representative in Folium.


CEO of Vesper Biotechnology

Board Representative: Folium Science

Paul Littles portfolio

Portrait of Paul Little
+45 3912 8083
pl@lundbeckfonden.com